FDA label
What is diclofenac used for?
The FDA-approved uses of diclofenac, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac sodium delayed-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS; Gastrointestinal Bleeding, Ulceration, and Perforation).”
Run it in Rivvi
Which 2027 plans near you dropped or restricted diclofenac?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Diclofenac Sodium, tablet, delayed release
Indications and Usage, quoted from the label by Umedica Laboratories USA Inc. (ANDA219945). Cross-references to other label sections are left out.
Carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac sodium delayed-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS; Gastrointestinal Bleeding, Ulceration, and Perforation).
Diclofenac sodium delayed-release tablets are indicated:
- For relief of the signs and symptoms of osteoarthritis
- For relief of the signs and symptoms of rheumatoid arthritis
- For acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis
Source: DailyMed label, set id 0e5c6669-390f-4c32-b9b8-13ed3c517462, version 6, effective January 30, 2026. NDC 60290-082, one of 120 listings for this product.
Diclofenac Sodium, solution
Indications and Usage, quoted from the label by Sun Pharmaceutical Industries, Inc. (ANDA203818). Cross-references to other label sections are left out.
Diclofenac sodium topical solution, USP is indicated for the treatment of signs and symptoms of osteoarthritis of the knee(s).
Source: DailyMed label, set id b60e6572-0624-40c5-e053-2995a90ade48, version 4, effective July 24, 2026. NDC 51672-1358, one of 66 listings for this product.
Diclofenac Sodium Topical, gel
Indications and Usage, quoted from the label by Alembic Pharmaceuticals Limited (ANDA212351). Cross-references to other label sections are left out.
Diclofenac sodium topical gel is indicated for the topical treatment of actinic keratoses (AK).
Source: DailyMed label, set id 11adfe0f-e774-4ccf-8a57-0c7d47aeb0dd, version 1, effective March 4, 2025. NDC 46708-581, one of 49 listings for this product.
Questions
What is diclofenac used for?
The FDA label says: “Carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac sodium delayed-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS; Gastrointestinal Bleeding, Ulceration, and Perforation).”
What drug class is diclofenac?
FDA lists diclofenac in the Nonsteroidal Anti-inflammatory Drug established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Diclofenac
- Is Diclofenac a controlled substance?Federal schedule
- Generic for ZipsorFDA Orange Book
- Generic for CambiaFDA Orange Book
- Generic for SolarazeFDA Orange Book
- Generic for VoltarenFDA Orange Book
- Generic for ZueinoFDA Orange Book
- Generic for PennsaidFDA Orange Book
- Generic for Voltaren-xrFDA Orange Book
- Generic for CataflamFDA Orange Book
- Nonsteroidal Anti-inflammatory Drugs listFDA drug class
- Diclofenac Medicare Part D coverageBy plan and state
- NDC 13913-008Diclofenac NDC record
- NDC 13913-012Diclofenac NDC record
- NDC 82497-008Diclofenac NDC record